Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-156173

Chief Scientific Officer gave up 441 shares (to pay taxes)

  • Chief Scientific Officer acquired 1,450 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shanler Stuart · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-12-18 Exercise or conversion : show line 1 in the form +1,450 262,319 D
2016-12-18 Shares withheld for taxes : show line 2 in the form −441 $31.25 $13,781 261,878 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-12-18 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,450 4,350 D
Loading xslF345X03/doc4.xml…